key: cord-0703910-uh14r3gx
authors: Tang, Julian W.; Kwok, Kin On
title: Learning from and optimising divergent pandemic responses
date: 2022-04-07
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2022.03.038
sha: 852c545256ba18253fcf03e4976eaeb998029404
doc_id: 703910
cord_uid: uh14r3gx

nan

Recent events in Hong Kong related to the spread of the SARS-CoV-2 Omicron variant may seem very familiar to those in the West, where such rapid spread of the virus was seen during the first wave of the pandemic during March-June 2020. The comparison is made more dramatic in that this has occurred in a Hong Kong This led to fewer than 13,000 total recorded COVID-19 cases and only around 230 deaths in the territory, by the end of December 2021.

However, such success in the use of non-pharmaceutical interventions (NPIs) and potential distrust in government led to greater suspicion around the rapid development and licensing of the COVID-19 vaccines, as well as disproportionately severe anxieties about their rarer, more severe adverse effects [4] . Such concerns increased vaccine hesitancy and reduced the urgency to be vaccinated in much of the population, ultimately leading to a relatively slow uptake of any COVID-19 vaccine, with less than 70% of the population fully vaccinated by one year after the vaccination programme began.

The arrival of the more transmissible and immune-escape capable, though clinically relatively milder Omicron variant, together with the persistent 'zero COVID' policy or 'dynamic zero COVID', further increased the strain on an otherwise well-equipped healthcare service, run by the Hong Kong Hospital Authority.

So what can we learn from this? The ideal pandemic response would prioritise and enforce the use of NPIs to control the virus effectively whilst developing vaccines and antiviral drugs. Once such pharmaceutical interventions are available, populations need to take up any offered vaccine quickly, accepting that there will be some common minor and some rarer major adverse reactions to the vaccines. However, as we have seen during this pandemic, different governments and their populations will react differently at different times to the spread of the virus [5] , and this is very difficult to control at a global level.

The slow response and implementation of NPIs, followed by a rapid vaccine uptake in the West, contrasting with a rapid response and implementation of NPIs followed by a slow vaccine uptake in the East -each leading to their own local peaks of COVID-19 cases and deaths. A more effective global pandemic response should clearly consist of a balance of these two extreme responses -to optimise the use and timing of NPIs to buy time for a quick and efficient rollout of an effective vaccine for all populations.

Transparency statement: None of the authors have any financial or other conflicts of interest to declare. No funding was required for this article.

Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination

Estimation of early phase local-to-local transmissibility and importation hazard of Coronavirus Disease 2019 (COVID-19) epidemic under assorted containment measures in Hong Kong

What can countries learn from Hong Kong's response to the COVID-19 pandemic?

Lack of Trust, Conspiracy Beliefs, and Social Media Use Predict COVID-19 Vaccine Hesitancy. Vaccines (Basel)

An exploration of the political, social, economic and cultural factors affecting how different global regions initially reacted to the COVID-19 pandemic. Interface Focus

Author Credit statement: JWT conceived and drafted the first version of this manuscript. KKOK added further details and data on the spread of COVID-19 in the Hong Kong population. Both authors critically reviewed and made final edits to the manuscript prior to submission.